Table 1.
Characteristics | N (%) |
---|---|
DENV serotypes | |
Mono-infection | 222 (84.7) |
DENV-1 | 170 (76.6) |
DENV-2 | 44 (19.8) |
DENV-3 | 7 (3.2) |
DENV-4 | 1 (0.5) |
Co-infection | 40 (15.3) |
DENV-1/DENV-2 | 34 (85) |
DENV-1/DENV-3 | 5 (12.5) |
DENV-2/DENV-3 | 1 (2.5) |
Race | |
Malay | 157 (59.9) |
Chinese | 34 (13) |
Indian | 29 (11.1) |
Foreign workers | 37 (14.1) |
Others | 5 (1.9) |
Male | 146 (55.7) |
Age groups | |
<18 | 38 (14.5) |
18-29 | 104 (39.7) |
30-39 | 64 (24.4) |
40-49 | 27 (10.3) |
50-59 | 17 (6.5) |
>60 | 12 (4.6) |
Pregnancy | 14 (5.3) |
Comorbiditiesa | 52 (19.8) |
Diabetes mellitus | 21 (8) |
Hypertension | 15 (5.7) |
Asthma | 14 (5.3) |
Cardiovascular disease | 6 (2.3) |
Blood disorderb | 4 (1.5) |
Malignancyc | 4 (1.5) |
Psychiatric disorders | 4 (1.5) |
Othersd | 5 (1.9) |
aA patient may have more than one comorbidities
bIncludes G6PD deficiency (n = 2), beta-thalassaemia (n = 1), von Willebrand disease (n = 1)
cIncludes cancer of breast (n = 1), ear (n = 1), pancreas (n = 1), ovary (n = 1)
dOne patient each had- chronic obstructive airway disease, military tuberculosis, splenectomy, end stage renal failure, systemic lupus erythematosus